Secretome of Cancer-Associated Fibroblasts (CAFs) Influences Drug Sensitivity in Cancer Cells
Journal of Proteome Research · 2024
DOI: 10.1021/acs.jproteome.4c00112 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteome Research, 2024. Verfasst von Rachel Lau und 6 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United…. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Secretome. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK, National Institute for Health and Care Research, Royal Marsden NHS Foundation Trust.
Abstract (Originalsprache)
Resistance is a major problem with effective cancer treatment and the stroma forms a significant portion of the tumor mass but traditional drug screens involve cancer cells alone. Cancer-associated fibroblasts (CAFs) are a major tumor stroma component and its secreted proteins may influence the function of cancer cells. The majority of secretome studies compare different cancer or CAF cell lines exclusively. Here, we present the direct characterization of the secreted protein profiles between CAFs and KRAS mutant-cancer cell lines from colorectal, lung, and pancreatic tissues using multiplexed mass spectrometry. 2573 secreted proteins were annotated, and differential analysis highlighted understudied CAF-enriched secreted proteins, including Wnt family member 5B (WNT5B), in addition to established CAF markers, such as collagens. The functional role of CAF secreted proteins was explored by assessing its effect on the response to 97 anticancer drugs since stromal cells may cause a differing cancer drug response, which may be missed on routine drug screening using cancer cells alone. CAF secreted proteins caused specific effects on each of the cancer cell lines, which highlights the complexity and challenges in cancer treatment and so the importance to consider stromal elements.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Clinical Pharmacology and Adaptive Therapy Group, The Institute of Cancer Research and The Royal Marsden NHS Foundation Trust, London SM2 5PT, United Kingdom.
- Functional Proteomics Group, Chester Beatty Laboratories, The Institute of Cancer Research, London SW3 6JB, United Kingdom.
ORCID-Profile: Theodoros I Roumeliotis, Udai Banerji
Förderung
- Cancer Research UK
- National Institute for Health and Care Research
- Royal Marsden NHS Foundation Trust
- Institute of Cancer Research
Zitieren
APA
Lau, R., Yu, L., Roumeliotis, T. I., Stewart, A., Pickard, L., Choudhary, J. S., & Banerji, U. (2024). Secretome of Cancer-Associated Fibroblasts (CAFs) Influences Drug Sensitivity in Cancer Cells. Journal of Proteome Research. https://doi.org/10.1021/acs.jproteome.4c00112
Vancouver
Lau R, Yu L, Roumeliotis TI, Stewart A, Pickard L, Choudhary JS, et al. Secretome of Cancer-Associated Fibroblasts (CAFs) Influences Drug Sensitivity in Cancer Cells. Journal of Proteome Research. 2024. doi:10.1021/acs.jproteome.4c00112
BibTeX
@article{Lau2024,
author = {Lau, Rachel and Yu, Lu and Roumeliotis, Theodoros I and Stewart, Adam and Pickard, Lisa and Choudhary, Jyoti S and Banerji, Udai},
title = {Secretome of Cancer-Associated Fibroblasts (CAFs) Influences Drug Sensitivity in Cancer Cells},
journal = {Journal of Proteome Research},
year = {2024},
doi = {10.1021/acs.jproteome.4c00112}
}
EUVIMED